ASML in focus as second guidance raise flags AI chip production still accelerating

ASML (ASML) is in focus Wednesday after the equipment maker raised its sales forecast for a second time this year, with shares gaining 3% on the session. Customers are still expanding their AI chip production capacity, the company said. That continued ramp is what pushed the outlook above the level set after the first revision earlier this year.

The second print and what it changes

A single upward guidance revision tells you demand came in above the company's opening estimate. Two in a calendar year tells you demand has stayed elevated through the period. ASML said its customers are still ramping AI chip production capacity, which means orders for the equipment those fabs require have held above the level the company modeled after its first update. The market's 3% session gain Wednesday prices in a longer run above prior guidance than one revision alone would support.

What the customer ramp means for the setup

Chipmakers building out AI production lines need lithography equipment. ASML is a key supplier in that chain, and when those customers accelerate capacity expansion, ASML's order flow follows directly. The second guidance raise shows the acceleration has continued through mid-year.

A first guidance raise can read as a conservative opening number getting corrected upward. The second arrives after customers have had months to recalibrate their own capital spending plans. That timing shifts the signal: it reflects a deliberate decision by customers to keep expanding AI chip capacity. Investors watching semiconductor equipment names have been looking for this kind of confirmation that spending is durable, and the pair of revisions provides it.

What to watch

The confirmable milestone is ASML's next earnings report, which will show whether the order trend that produced two guidance raises is holding or beginning to moderate. If customer capital spending on AI chip capacity continues at its current pace, the tape will start pricing the possibility of a third revision. Two raises in a single calendar year already marks an unusual run.